Objective
The processes involved in the formation of atherosclerotic lesions include: i) the proliferation of vascular smooth muscle cells (VSMC), macrophages and possibly Iymphocytes; ii) the formation by VSMC of a connective tissue matrix comprising elastic fibre proteins, collagen and proteoglycans; and iii) the accumulation of lipid and mostly free and esterified cholesterol in the surrounding matrix and the associated cells. Among several growth factors and cytokines platelet-derived growth factor (PDGF) has been shown to be essentially involved in atherosclerosis. It is generally not expressed in the normal artery, whereas it is upregulated in lesions of atherosclerosis. We have recently shown that PDGF stimulates human VSMC, in culture, to secrete a specific form of hyaluronic acid (HA), with molecular mass of 340 kDa, which has a potent antiproliferative activity on VSMC. These results suggest that VSMC in response to PDGF are capable of controlling their own growth by the synthesis of this specific 340-kDa HA molecule which may be involved in the regulation of the local inflammatory processes associated with atherosclerosis.
In the present study we are going to investigate: a) The molecular mechanism by which the 340-kDa HA inhibits VSMC proliferation. b) The effect of the 340kDa HA on VSMC migration and c) The presence of this molecule in the different layers of human atheromatic arterial walls as compared with normal arteries. Such information will highlight a further fascinating facet of the complex regulatory network controlling VSMC growth and migration in vessels and will have farreaching implications for our understanding of the pathophysiological mechanisms contributing to the formation of atherosclerotic lesions.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine cardiology cardiovascular diseases arteriosclerosis
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences biological sciences biochemistry biomolecules lipids
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
1090 Wien
Austria
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.